PDLI-17.58% The next "MAJOR NEWS" item is ……… The stock’s price-to-earnings (P/E) ratio stands at --4.91 on (NASDAQ). http://www.wikinvest.com/stock/PDL_BioPharma_(PDLI)/Data/Key_Metrics
cut that in half with the revenue loss going forward...a 10p/e for a stock with negative momentum and huge uncertainty...the "new" 9 p/e will go to 5 p/e again...meaning expect 2.50 pps coming. Cheers!
This seems like Medimune redux. Anyone want to start the conspiracy rumor?